News

2024 New Investigator Awards is open!

By Fattin Wekselman on November 13, 2023
To learn more, please register to the upcoming webinar visit https://go.naccdata.org/nov-16-new-investigator-award-webinar

Tia LaMore was chosen as a fellow for the Brighfocus Fasttrack 2023

By Fattin Wekselman on November 05, 2023
Tia LaMore was chosen as a fellow for the Brightfocus Fasttrack 2023- an immersive Alzheimer's disease research grant writing workshop for early career investigators. Link to program: https://science.brightfocus.org/event/alzheimers-fast-track-2023

Ian Oh's winning poster on preliminary findings on the distribution of truncated tau isoform in progressive AD

By Fattin Wekselman on June 19, 2023
Ian Oh, Grinberg lab's staff research associate received 3rd place for his poster titled "Truncated tau pathology in progressive stages of AD: a story not told by hyperphosphorylated tau burden. Which comes first?"

Gowon Son, Ph.D. AAIC 2023 Conference Fellowship Award

June 18, 2023
Congratulations to Gowoon Son, Ph.D. for being awarded a Conference Fellowship for the Alzheimer’s Association International Conference® 2023 (AAIC®) will be hosted in Amsterdam, Netherlands on July 16-20, 2023. Her abstract titled "Selective vulnerability of the suprachiasmatic nucleus in...

A podcast with Connor Wander "Deep Brain Degeneration in Alzheimer’s Disease with Dr. Lea Grinberg & Research Team"

By Fattin Wekselman on May 30, 2023
Connor Wander from the UNC-Chapel hill had a conversation with Dr. Grinberg on Deep Brain Degeneration in Alzheimer’s Disease and conversation with the Grinberg lab on Losing Control from the Locus Coeruleus.

Congratulations to Lea Grinberg and Daniela Ushizima winners of the PMWC Pioneer Award for developing a new and reliable technique for diagnosing Alzheimer’s disease and measuring the eficacy of experimental treatments.

By Fattin Wekselman on January 27, 2023
Winners of the PMWC Pioneer Award for developing a new and reliable technique for diagnosing Alzheimer’s disease and measuring the ef cacy of experimental treatments.

Alzheimer's drug lecanemab slows cognitive decline but concerns linger

By Grace Wade on December 01, 2022
The lecanemab group also had substantial decreases to the number of misfolded proteins in the brain called tau tangles. These proteins increased in the control group. “Tau is the abnormal protein in Alzheimer’s disease that has the best correlation with clinical decline,” says Lea Grinberg at the...

Best postdoctoral poster competition award AAIC 2022

By Abhijjit Satpati on September 30, 2022
Grinberg lab's very own Postdoc Abhijit Satpati

Loss of Neurons, Not Lack of Sleep, Makes Alzheimer’s Patients Drowsy Reviving “Awake Neurons” Could Be the Solution to Their Sleepiness, UCSF Study Shows

By Robin Marks on April 04, 2022
The lethargy that many Alzheimer’s patients experience is caused not by a lack of sleep, but rather by the degeneration of a type of neuron that keeps us awake, according to a study that also confirms the tau protein is behind that neurodegeneration. The study’s findings contradict the common...

Ladders Inc.: This very normal habit could be a symptom of Alzheimer’s Disease

By CW Headley on October 27, 2021
This article was updated on August 12, 2021. A report published in the Journal of Alzheimer’s and Dementia, posits that toxic clumps of a protein called tau might be what causes Alzheimer’s disease.

Pages